GlassScriptPhysician profile
Kevin J Sheahan
NPI 1902900582
$5,620.12
in general payments reported to CMS, 2019-2025
43 companies · none reported in 2025
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,159 · 2020: $875 · 2021: $1,484 · 2022: $1,701 · 2023: $356 · 2024: $45.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,443.28 | 2019-2022 | |
| Abbvie INC. | $455.56 | 2021-2023 | Qulipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $430.11 | 2019-2023 | Relistor |
| Collegium Pharmaceutical, INC. | $337.35 | 2019-2022 | |
| Allergan, INC. | $291.90 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $271.37 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $231.68 | 2019-2020 | |
| Tersera Therapeutics LLC | $230.48 | 2019-2021 | |
| Flowonix Medical Incorporated | $210.87 | 2019-2020 | |
| Redhill Biopharma INC. | $178.50 | 2020-2022 | |
| Zyla Life Sciences, INC. | $168.60 | 2019-2020 | |
| Amgen INC. | $165.57 | 2019-2022 | |
| Abbott Laboratories | $119.33 | 2021 | |
| Novartis Pharmaceuticals Corporation | $80.28 | 2019-2021 | |
| Sentynl Therapeutics, INC. | $79.47 | 2019 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Sheahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.